ice7
Lv6
1688 积分
2024-10-28 加入
-
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children
13天前
已关闭
-
Antibody Persistence in Chinese Toddlers at 1 Year and 2 Years after Two Different 4-Dose Schedules of a Novel 13-Valent Pneumococcal Conjugate Vaccine (Pcv13-Tt)
13天前
已完结
-
Antibody Persistence in Chinese Toddlers at 1 Year and 2 Years after Two Different 4-Dose Schedules of a Novel 13-Valent Pneumococcal Conjugate Vaccine (Pcv13-Tt)
13天前
已关闭
-
Persistence of immunity in children aged 2 months and 7 months – 5 years old after primary immunization with 13-valent pneumococcal conjugate vaccine
13天前
已完结
-
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial
23天前
已完结
-
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial
23天前
已完结
-
Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial
1个月前
已完结
-
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination
1个月前
已完结
-
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial
1个月前
已完结
-
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial
1个月前
已完结